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http:WHAT THIS PAPER ADDS
Single-session endovascular treatment with MAT as the ﬁrst-line thrombus removal method is feasible, safe, and
effective for IVCS with secondary acute isolated iliofemoral DVT, and can result in more efﬁcient patient care.Objective: To evaluate the feasibility, safety, and effectiveness of single-session endovascular treatment with
manual aspiration thrombectomy (MAT) as the ﬁrst-line method of thrombus removal for iliac vein compression
syndrome (IVCS) with secondary acute isolated iliofemoral deep vein thrombosis (DVT).
Methods: This was a prospective clinical study. Twenty-six patients (19 women, 7 men, mean age 54 years) with
left-sided acute iliacecommon femoral DVT secondary to IVCS were enrolled. All patients presented with leg
swelling or pains. Endovascular treatment, consisting of MAT, balloon angioplasty, and stent placement, was
performed in the same setting. Overnight antegrade thrombolysis was performed in patients with residual
thrombus after MAT. Patients were followed up by ultrasonography. The mean follow-up period was 17.8 months
(12e25 months).
Results: Single-session endovascular procedures were performed successfully in all patients. The mean procedure
time was 67 minutes (ranging from 45 to 90 minutes). Complete thrombus removal, including almost 100% of
removal in 24 patients and little residual thrombus (<5%) in two, was achieved after repeated MAT. Thrombolysis
was used in these two patients. Complete symptomatic relief was achieved in 25 patients (96%) and partial relief
in one. The hospital stay ranged from 2 to 4 days (mean 2.7 days). Recurrent thrombosis within the stent was
observed in one case and recanalized with thrombolysis. The 1-year primary and secondary patency rate was 96%
and 100%, respectively. No symptomatic pulmonary embolization, bleeding, and venous reﬂux were observed.
Five patients complained about transitory low back pains during balloon angioplasty.
Conclusion: Single-session endovascular treatment with MAT as the ﬁrst-line thrombus removal method is
feasible, safe, and effective for IVCS with secondary acute isolated iliofemoral DVT. Although limited, our
experience suggests that patients thought to be at high risk of bleeding may be candidates for the present single-
session endovascular protocol.
 2013 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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Iliac vein compression syndrome (IVCS), also known as
MayeThurner syndrome, is believed to be caused by
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//dx.doi.org/10.1016/j.ejvs.2013.09.030between the overlying right common iliac artery and the
vertebral body, and it has been considered an anatomic
risk factor for the left-sided deep vein thrombosis
(DVT).1e3 Approximately 50e60% of patients presenting
with left-sided iliofemoral DVT are found to have common
iliac vein synechiae or intraluminal web resulting from
vein wall contact and compression.4 The rate of recur-
rence (73%) is high in patients with acute left-sided ilio-
femoral DVT when the IVCS is not treated with stent
placement.5 This group of patients may be put at partic-
ularly high risk for post-thrombotic syndrome (PTS) and
late disability.
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thrombolysis (CDT), percutaneous mechanical thrombec-
tomy (PMT), and stent placement, are currently considered
to be the mainstay for DVT secondary to IVCS.6,7 Although
it may enhance thrombus lysis and prevent PTS, CDT has
some speciﬁc disadvantages, such as the risk of bleeding,
the long time to lysis, long hospital stay, and heavy eco-
nomic cost incurred by the need for close monitoring,
which may impede its widespread utilization.6e10 PMTmay
increase the efﬁciency of thrombus clearance and lower
the infusion dose and time of the thrombolytic agent,11e13
but it may cause damage to vessel walls and valves,
and even have the risk of pulmonary embolization (PE).6
Besides, PMT devices may cause hemolysis and
hemoglobinuria.14
Manual aspiration thrombectomy (MAT) is an effective
and rational option for thrombus removal due to its ad-
vantages of rapidity and avoidance of bleeding complica-
tions.15,16 Theoretically, MAT can result in more efﬁcient
patient care. The purpose of the present study was to
prospectively evaluate the feasibility, safety, and effective-
ness of single-session endovascular treatment with MAT as
the ﬁrst-line thrombus removal method for the treatment
of IVCS with secondary acute isolated iliacecommon
femoral DVT.Figure 1. Computed tomography (CT) evaluation of the underlying sten
image demonstrates considerable compression of the left common ili
mation along the left iliofemoral vein demonstrates extrinsic compress
artery and the spine. (C) Volume-rendered image shows lack of visua
stenosis of the left common iliac vein caused by compression of the
extension to the inferior vena cava.MATERIALS AND METHODS
Patient population
This study was approved by the institutional review board
and the ethics committee of our university. From July 2010
to June 2012, 26 consecutive patients with left-sided acute
(1e14 days) isolated iliacecommon femoral DVT due to
IVCS were enrolled in the present prospective study based
on the following inclusion and exclusion criteria. DVT was
diagnosed based on the clinical and imaging ﬁndings. Color
Doppler ultrasonography (CDU) was the most commonly
used for imaging ﬁndings of DVT. IVCS were diagnosed by
spiral computed tomographic (CT) venography. The patients
were included in the study if they had stenosis or occlusion
of the left common iliac vein (50% luminal diameter
reduction) caused by compression of the right common iliac
artery and the vertebral body demonstrated by CT images
(including cross-sectional images and images after three-
dimensional construction using curved planar reformation
and volume rendering) (Fig. 1), and thrombosis in any part
of the iliac vein and/or the common femoral vein (Fig. 2).
The patients were excluded from the study if they had
thrombosis in the femoral vein, popliteal vein, or inferior
vena cava (IVC), active internal bleeding, a recent cerebro-
vascular accident, allergy to thrombolytic agents, recentosis or obstruction and the extent of thrombus. (A) Cross-sectional
ac vein by the right common iliac artery. (B) Curved planar refor-
ion of the left common iliac vein between the right common iliac
lization of the left iliofemoral vein. (D, E) CT images demonstrate
right common iliac artery and the vertebral body, and thrombus
Figure 2. A 72-year-old woman with acute pain and leg swelling in the left lower extremity due to acute iliofemoral deep vein thrombosis
(DVT) secondary to iliac vein compression syndrome. (A) Initial venography in the prone position shows acute iliofemoral DVT. (B) Clinical
photograph shows the thrombus aspirated out. (C) A venogram after manual aspiration thrombectomy shows stenosis of the common iliac
vein and collateral formation. (D) The stenotic iliac vein was dilated with an angioplasty balloon. (E) A venogram after stent deployment
shows a patent common iliac vein, good antegrade ﬂow, abolition of collaterals and little residual thrombus. (F) The ﬁnal venogram shows
a patent common iliac vein and no residual thrombus was shown after overnight thrombolysis.
70 Q.H. Zhu et al.serious gastrointestinal bleeding, recent serious trauma,
severe hypertension, pregnancy, coagulopathy, malignancy
with less than 1-year estimated survival, or contraindica-
tions to the use of anticoagulation or contrast media.
Among the enrolled 26 patients, there were 19 women
and 7 men with a mean age of 54 years (aged between 33
and 79 years). All patients presented with leg swelling or
pains in the left lower extremity. The duration of symptoms
ranged from 1 to 11 days (average 5.2 days). Four of them
presented with symptoms for 4 days after hysterectomy
because of hysteromyoma. Other risk factors for develop-
ment of DVT, except IVCS, included immobilization (n ¼ 8),
bony fractures (n ¼ 3), postpartum state (n ¼ 3), while noother obvious risk factors were found in eight of them
(Table 1). Hematologic abnormalities such as protein S or
protein C deﬁciency, or Factor V Leiden mutation were not
routinely searched in the present study.
Single-session endovascular procedures
Informed consents were obtained from all the patients prior
to procedures. All authors have experience in interventional
radiology of more than 5 years. All of the endovascular
procedures, including MAT, balloon angioplasty, and stent
placement, were performed in the same setting. Prophy-
lactic IVC ﬁlter placement was not planned in this group of
patients.
Table 1. The characteristics of deep vein thrombosis secondary to iliac vein compression syndrome and the outcome of single-session endovascular treatment.
Pt. no. Age
(sex)
Symptom
duration
(days)
Other risk
factors
Thrombus location Procedure
time (min)
Complications Thrombus
removal
Clinical
outcome
Hospital
stay (days)
Follow-up
duration
(months)
1 51/F 2 Immobilization Iliac vein and common femoral 68 None Nearly 100% Complete 3 25
2 62/F 5 Unknown Iliac vein and common femoral 75 None Nearly 100% Complete 2 24
3 66/F 4 Bony fracture Iliac vein and common femoral 90 None Nearly 100% Complete 3 24
4 57/M 2 Unknown Iliac vein 50 None Nearly 100% Complete 3 23
5 79/M 9 Immobilization Iliac vein and common femoral 72 Transitory pain Nearly 100% Partial 3 22
6 43/F 4 Surgery Iliac vein and common femoral 55 None Nearly 100% Complete 2 22
7 49/F 7 Surgery Iliac vein and common femoral 86 None Nearly 100% Complete 2 21
8 42/M 3 Immobilization Iliac vein and common femoral 82 Transitory pain Nearly 100% Complete 2 21
9 56/F 4 Immobilization Iliac vein 48 Transitory pain Nearly 100% Complete 3 20
10 33/F 5 Postpartum Iliac vein and common femoral 62 None Nearly 100% Complete 3 20
11 66/F 5 Unknown Iliac vein and common femoral 48 None Nearly 100% Complete 2 19
12 57/F 3 Unknown Iliac vein and common femoral 75 None Nearly 100% Complete 2 18
13 35/F 4 Bony fracture Iliac vein and common femoral 76 Transitory pain Nearly 100% Complete 3 17
14 75/M 1 Immobilization Common iliac 45 None Nearly 100% Complete 2 17
15 73/M 11 Unknown Iliac vein and common femoral 85 None <5% residual Complete 4 16
16 46/F 4 Surgery Iliac vein and common femoral 72 None Nearly 100% Complete 2 16
17 55/F 4 Immobilization Iliac vein and common femoral 76 None Nearly 100% Complete 3 15
18 35/F 10 Postpartum Iliac vein and common femoral 70 None Nearly 100% Complete 4 15
19 70/M 8 Unknown Iliac vein and common femoral 66 None Nearly 100% Complete 4 15
20 68/F 6 Bony fracture Iliac vein 55 None Nearly 100% Complete 2 14
21 49/F 10 Unknown Iliac vein and common femoral 82 Transitory pain <5% residual Complete 4 14
22 65/F 2 Immobilization Common iliac 50 None Nearly 100% Complete 3 14
23 57/F 6 Surgery Iliac vein and common femoral 63 None Nearly 100% Complete 2 13
24 46/M 4 Immobilization Iliac vein and Common femoral 70 None Nearly 100% Complete 2 13
25 35/F 5 Postpartum Iliac vein and common femoral 68 None Nearly 100% Complete 3 12
26 54/F 7 Unknown Iliac vein and common femoral 58 None Nearly 100% Complete 3 12
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72 Q.H. Zhu et al.Patients were placed in the prone position on the
angiographic table. The ipsilateral popliteal vein was punc-
tured under ultrasonography after the left popliteal fossa
had been prepared in a sterile manner. A 21-gauge micro-
puncture needle set (Cook, Bloomington, IN, USA) was used
to access the vein. After placement of a 10F vascular sheath
(Cordis, Amsterdam, the Netherlands), an ascending
venography was performed (Fig. 2A). Then a 9F guiding
catheter (Vista Brite, Cordis) used for MAT was introduced
into the thrombus-ﬁlled iliacecommon femoral vein via a
guidewire. The guiding catheter was gently moved back and
forth and rotated to aspirate the thrombus while negative
pressure was maintained using a 20-mL syringe. During the
dynamic movement of the aspiration catheter, a large
thrombus could be remodeled and aspirated out (Fig. 2B). If
blocked up a by large thrombus, the guiding catheter had to
be pulled out of the sheath. Suitable negative pressure was
maintained during this process. Repeated MAT was per-
formed until the thrombus within the aspiration catheter
was washed out. Venography was performed to evaluate
the thrombus burden in the process of aspiration, and
repeated aspiration was performed until more than 95% of
the thrombus was cleared up before reconstruction of the
iliac vein (Fig. 2C). After crossing the lesion with a hydro-
philic guidewire, the stenotic or occlusive iliac vein was
dilated using a balloon catheter (C.R. Bard, Murray Hill, NJ,
USA) (Fig. 2D) and then a self-expandable nitinol stent
(Luminexx, C.R. Bard) was placed. A ﬁnal venography was
performed to conﬁrm that antegrade in-line ﬂow from the
popliteal vein to the IVC was restored, and the stenosis or
occlusion of the iliac vein was eliminated (Fig. 2E). Over-
night antegrade thrombolysis through the popliteal sheath
with urokinase (total 800,000 units, lasting for 12 hours)
was performed if little residual thrombus was shown
(Fig. 2E). Another venography was performed to assure
complete clearance of the residual thrombus (Fig. 2F).
Periprocedural management and follow-up
Low molecular weight heparin (Nadroparin, GlaxoSmithK-
line, Tianjin, China) 4,100 IU twice a day for 5e7 days and
warfarin sodium 1.25e5 mg once per day were adminis-
tered when DVT was diagnosed. After endovascular therapy,
anticoagulation therapy with warfarin sodium for a mini-
mum course of 6 months was conducted to maintain the
international normalized ratio in the range of 2.0e3.0. All
patients were to be followed-up at the interventional
radiology outpatient clinic at 1, 3, 6, and then every 6
months for the ﬁrst 2 years, and once every year thereafter.
At each clinical visit, CDU was performed to detect the
patency of the stent and the deep vein system, and to
detect any reﬂux present. All patients were present at all of
the follow-up visits.
Assessment of treatment and deﬁnitions
Treatment efﬁcacy and safety were assessed based on
the guidelines published by the American Society of
Interventional Radiology on lower extremity deep veinthrombosis.17 Clinical success, technical success, and pri-
mary and secondary patency were deﬁned according to the
guidelines. Procedure time was counted from the point
when the popliteal vein was punctured to the point when
the ﬁnal venography was performed after the stent was
placed. Removal of the thrombus by <50% after repeated
MAT was scaled as minimal (grade I); by 50e95%, as partial
(grade II); and by >95%, as complete (grade III).
Complications were deﬁned as procedure-related com-
plications such as major vessel wall damage and blood loss
secondary to MAT, symptomatic PE, acute thrombosis in the
stent, stent migration, and thrombolysis-related complica-
tions such as bleeding and hematoma. Major vessel wall
damage could be identiﬁed when contrast agent stagnation
in the vessel wall or diffusion outside the vessel was
observed in venography. The major bleeding-associated
complications were intracranial bleeding, and severe
bleeding necessitating transfusion or surgery, or causing
death or cessation of thrombolytic therapy. Minor compli-
cations included minimal bleeding or hematoma, fever,
pain, and nausea and vomiting.Statistical analysis
Data were expressed as the mean  standard deviation for
continuous variables and percentages for categorization.
Hemoglobin levels before and right after endovascular
procedures were compared using the paired Student t test.
Statistical analyses were performed using SPSS version 16.0
(SPSS, Chicago, IL, USA).RESULTS
Efﬁcacy outcomes
Single-session endovascular procedures were performed
successfully in all patients, with a technical success rate of
100%. The procedure time varied from 45 to 90 minutes
(average 67 minutes). Complete thrombus removal,
including nearly 100% in 24 patients and little residual
thrombus (<5%) that disappeared from our observation
overnight in two patients, was achieved after repeated
MAT. The thrombus in the four patients who underwent
hysterectomy was completely removed without the use of
thrombolytic agents (Table 1). Venography after thrombus
removal demonstrated collateral formations in the distal
iliac veins. Stenosis of the iliac vein was observed in 24
patients and occlusion in two patients. Recanalization of the
left iliac vein was successful in all patients and a total of 26
stents, 10e14 mm in diameter and 60e100 mm in length,
were placed.
Complete symptomatic relief was achieved in 25 patients
(96%) and partial relief in one patient within a week after
procedures. The hospital stay ranged from 2 to 4 days
(average 2.7 days) (Table 1). During the follow-up periods,
recurrent thrombosis in the stent was detected in one pa-
tient 11 months after the procedures. After CDT, successful
restoration of antegrade in-line ﬂow within the stent was
obtained. Overall, primary and secondary patency rates
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from 12 to 25 months (average 17.8 months).Safety outcomes
Major damage to the vessel wall related to the MAT was
not observed. None of the patients in this group experi-
enced symptomatic PE and bleeding complications. No
reﬂux was detected in any of the patients. The mean
decrease in the hemoglobin level after procedures was
1.2 g/dL and there was no signiﬁcant difference compared
with the preprocedural level (p ¼ .00). Five patients com-
plained of transitory low back pain during balloon
angioplasty.
DISCUSSION
Although quality improvement guidelines for the treatment
of lower extremity DVT have been published by the
American Society of Interventional Radiology and the So-
ciety for Vascular Surgery,7,14 catheter-based endovascular
methods differ from center to center. CDT plus anticoagu-
lant therapy is an acceptable initial treatment strategy for
many patients with acute iliofemoral DVT because of its
consistent success in the removal of thrombus and the
potential to prevent PTS. A pooled analysis revealed that
major bleeding, due to administration of large dosages of
thrombolytic agents and prolonged infusion time, was the
most frequent major complication of CDT and was observed
in approximately 8% of patients undergoing treatment.8
Adjunctive PMT devices, such as Angiojet, ATD, Trellis-8,
EKOS Endowave, have been designed to offer an
appealing endovenous solution for aggressive thrombus
removal. A systemic review demonstrated that a technical
success of 82e100% was achieved with grade II or III lysis
(50% luminal patency) in 83e100% of patients.13 As well
as disadvantages mentioned before, PMT devices are
signiﬁcantly costly.
The results of the present study demonstrated that MAT
can not only provide a rapid and effective means for the
treatment of acute isolated iliacecommon femoral DVT due
to IVCS, but also be adopted as a ﬁrst-line thrombus
removal method for this appropriately selected group of
patients. Based on the rapidness and effectiveness of MAT,
single-session endovascular treatment is technically
feasible. Following MAT, the underlying iliac stenosis or
occlusion can be treated in the same setting, which may
contribute to more efﬁcient patient care. Another advan-
tage of the current technique is the excellent performancee
price ratio. Fresh thrombus and relatively lower thrombus
burden result in good response to MAT alone. Compared
with that of CDT, the effectiveness of MAT was predominant
in this patient group,17 so that administration of urokinase
was limited in only two patients, and bleeding complica-
tions were thus not observed. In this study, two patients
presented with symptoms 4 days after hysterectomy, which
was considered a contraindication to the use of thrombo-
lytic agent. However, complete removal of the thrombus
was achieved by MAT alone.PE risks, vessel wall and valve damage, hemolysis, and
hemoglobinuria are the potential procedure-related com-
plications of PMT.6,14 In the present study, major damage to
the vessel wall related to the MAT manipulation was not
observed. To date, it is difﬁcult to evaluate damage to valves
and minor damage to vessel walls, such as damage to
endothelium. The present authors deduce that damage to
valves or vessel walls due to MAT may not be clinically
signiﬁcant, as illustrated in part by the fact that no reﬂux or
valve dysfunction was detected by CDU in the 1-year follow-
up. Long-term effects on the valvular function remain to be
evaluated in the future. Based on our results and those of
Oguzkurt L et al.,16 MAT is promising for removing the
thrombus in the femoral or popliteal vein.
Symptomatic PE was not observed in this study.We deduce
that the incidence of PE is probably lower because the
intraluminal synechiae may act as a simple obstructive barrier
in preventing the passage of large volumes of thrombus into
the IVC. Whether prophylactic IVC ﬁlter placement is neces-
sary or not in the treatment of acute DVT due to IVCS remains
controversial; during enrollment of patients for this study, we
had cases with thrombus extension to IVC, even though
evidently underlying venous stenosis at the left common iliac
vein was observed on CT images (Fig. 1D, E).
The anatomy of deep veins, the extent of thrombus, and
the underlying stenosis or obstruction is important infor-
mation in the management of DVT, especially for left-sided
cases with a high index of suspicion of IVCS. It is very
difﬁcult to accurately evaluate the underlying stenosis or
obstruction in patients with extensive acute iliofemoral DVT
by ascending venography alone, unless the thrombus has
been removed. In recent years, CT has proved to be useful
in evaluating the underlying anatomic abnormalities in pa-
tients with left-sided DVT.18,19 CT venography and three-
dimensional construction images are useful in selecting
patients appropriate for the present single-session endo-
vascular treatment (Fig. 1). Our results demonstrated that a
CT scan could provide great important information in
treatment planning for DVT.
Various studies have revealed that endovascular treat-
ment of DVT due to IVCS is feasible and effective, with 79e
100% primary patency rates in 1e2 years.3,5,20,21 Our results
are similar to those of previously reported series. Patency
during the long term, however, has to be assessed in the
future.
This study has certain limitations. We had a relatively
small study group with a single arm; larger groups and
comparative studies must be performed to ﬁrmly establish
the interventional protocol. The follow-up period was short,
and long-term follow-up is needed to conﬁrm safety and
effectiveness.
In conclusion, single-session endovascular treatment with
MAT as the ﬁrst-line thrombus removal method is feasible,
safe, and effective for the treatment of IVCS with secondary
acute isolated iliacecommon femoral DVT. Although
limited, our experience suggests that patients thought to be
at a high risk of bleeding may be suitable candidates for the
present single-session endovascular protocol.
74 Q.H. Zhu et al.FUNDING
None.
CONFLICT OF INTEREST
None.
REFERENCES
1 May R, Thurner JP. The cause of the predominately sinistral
occurrence of thrombosis of the pelvic veins. Angiology
1957;8:419e27.
2 Cockett FB, Thomas ML. The iliac compression syndrome. Br J
Surg 1965;52:816e21.
3 O’Sullivan GJ, Semba CP, Bittner CA, Kee ST, Razavi MK,
Sze DY, et al. Endovascular management of iliac vein
compression (May-Thurner) syndrome. J Vasc Interv Radiol
2000;11(7):823e36.
4 Mickley V, Schwagierek R, Rilinger N, Gorich J, Suder-
Plassmann L. Left iliac venous thrombosis caused by venous
spur: treatment with thrombectomy and stent implantation.
J Vasc Surg 1998;28:492e7.
5 Binkert CA, Schoch E, Stuckmann G, Largiader J, Wigger P,
Schoepke W, et al. Treatment of pelvic venous spur (May-
Thurner syndrome) with self-expanding metallic endopros-
theses. Cardiovasc Intervent Radiol 1998;21:22e6.
6 Nazir SA, Ganeshan A, Nazir S, Uberoi R. Endovascular treat-
ment options in the management of lower limb deep venous
thrombosis. Cardiovasc Intervent Radiol 2009;32:861e76.
7 Meissner MH, Gloviczki P, Comerota AJ, Dalsing MC, Eklof BG,
Gillespie DL, et al. Early thrombus removal strategies for acute
deep venous thrombosis: clinical practice guidelines of the
Society for Vascular Surgery and the American Venous Forum.
J Vasc Surg 2012;55:1449e62.
8 Mewissen WM, Seabrook GR, Meissner MH, Cynamon J,
Labropoulos N, Haughton SH. Catheter-directed thrombolysis
for lower extremity deep venous thrombosis: report of a na-
tional multicenter registry. Radiology 1999;211:39e49.
9 Baekgaard N, Broholm R, Just S, Jorgensen M, Jensen LP. Long-
term results using catheter-directed thrombolysis in 103 lower
limbs with acute iliofemoral venous thrombosis. Eur J Vasc
Endovasc Surg 2010;39:112e7.
10 Bækgaard N, Klitfod L, Broholm R. Safety and efﬁcacy of
catheter-directed thrombolysis. Phlebology 2012;27(Suppl. 1):
149e54.11 Kasirajan K, Gray B, Ouriel K. Percutaneous AngioJet throm-
bectomy in the management of extensive deep venous
thrombosis. J Vasc Interv Radiol 2001;12(2):179e85.
12 Lin PH, Zhou W, Dardik A, Mussa F, Kougias P, Hedayati N, et al.
Catheter-direct thrombolysis versus pharmacomechanical
thrombectomy for treatment of symptomatic lower extremity
deep venous thrombosis. Am J Surg 2006;192(6):782e8.
13 Karthikesalingam A, Young EL, Hinchliffe RJ, Loftus IM,
Thompson MM, Holt PJ. A systematic review of percutaneous
mechanical thrombectomy in the treatment of deep venous
thrombosis. Eur J Vasc Endovasc Surg 2011;41(4):554e65.
14 Vedantham S, Thorpe PE, Cardella JF, Grassi CJ, Patel NH,
Ferral H, et al. Quality improvement guidelines for the treat-
ment of lower extremity deep vein thrombosis with use of
endovascular thrombus removal. J Vasc Interv Radiol 2009;20(7
Suppl.):S227e39.
15 Kwon SH, Oh JH, Seo TS, Ahn HG, Park HC. Percutaneous
aspiration thrombectomy for the treatment of acute lower
extremity deep vein thrombosis: is thrombolysis needed? Clin
Radiol 2009;64(5):484e90.
16 Oguzkurt L, Ozkan U, Gulcan O, Koca N, Gur S. Endovascular
treatment of acute and subacute iliofemoral deep venous
thrombosis by using manual aspiration thrombectomy: long-
term results of 139 patients in a single center. Diagn Interv
Radiol 2012;18(4):410e6.
17 Vedantham S, Grassi CJ, Ferral H, Patel NH, Thorpe PE,
Antonacci VP, et al. Reporting standards for endovascular
treatment of lower extremity deep vein thrombosis. J Vasc
Interv Radiol 2009;20(7 Suppl.):S391e408.
18 Chung JW, Yoon CJ, Jung SI, Kim HC, Lee W, Kim YI, et al. Acute
iliofemoral deep vein thrombosis: evaluation of underlying
anatomic abnormalities by spiral CT venography. J Vasc Interv
Radiol 2004;15(3):249e56.
19 Oguzkurt L, Ozkan U, Ulusan S, Koc Z, Tercan F. Compression of
the left common iliac vein in asymptomatic subjects and pa-
tients with left iliofemoral deep vein thrombosis. J Vasc Interv
Radiol 2008;19(3):366e70.
20 Patel NH, Stookey KR, Ketcham DB, Cragg AH. Endovascular
management of acute extensive iliofemoral deep venous
thrombosis caused by May-Thurner syndrome. J Vasc Interv
Radiol 2000;11:1297e302.
21 Hurst DR, Forauer AR, Bloom JR, Greenﬁeld LJ, Wakeﬁeld TW,
Williams DM. Diagnosis and endovascular treatment of ilio-
caval compression syndrome. J Vasc Surg 2001;34:106e13.
